Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH)

BMJ Open Gastroenterology

Volumn 3, Issue 1, 2016, Pages

  Chawla, Kashmira S ^a   Talwalkar, Jayant A ^b   Keach, Jill C ^b   Malinchoc, Michael ^b   Lindor, Keith D ^c   Jorgensen, Roberta ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BIOCHEMICAL ANALYSIS; CHRONIC LIVER DISEASE QUESTIONNAIRE; CONSTRUCT VALIDITY; DEMOGRAPHY; EVALUATION STUDY; FEMALE; HUMAN; LIVER FUNCTION TEST; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; QUESTIONNAIRE; RELIABILITY; SCORING SYSTEM; SHORT FORM 36;

EID: 85038892351     PISSN: None     EISSN: 20544774     Source Type: Journal    
DOI: 10.1136/bmjgast-2015-000069     Document Type: Article

References (28)

1. Ludwig J, Viggiano TR, McGill DB, et al. Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-8.
2. Bacon BR, Farahvash MJ, Janney CG, et al. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994;107:1103-9.
3. James OFW, Day CP. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol 1998;29:495-501.
4. Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease. A spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-19.
5. Cheung O, Sanyal AJ. Recent advances in nonalcoholic fatty liver disease. Curr Opin Gastroenterol 2010;26:202-8.
6. Angulo P, Keach JC, Batts KP, et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356-62.
7. Charlton M, Kasparova P, Weston S, et al. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl 2001;7:608-14.
8. Martin LM, Younossi ZM. Health-related quality of life (HRQL) in chronic liver disease. Dig Liver Dis 2005;37:819-20.
9. Borgaonkar MR, Irvine EJ. Quality of life measurement in gastrointestinal and liver disorders. Gut 2000;47:444-54.
10. Ware JE, Kosinski M. Interpreting SF-36 summary health measures: a response. Qual Life Res 2001;10:405-13.
11. Wiebe S, Guyatt G, Weaver B, et al. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol 2003;56:52-60.
12. David K, Kowdley KV, Unalp A, et al. Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology 2009;49: 1904-12.
13. Dan AA, Kallman JB, Wheeler A, et al. Health-related quality of life in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2007;26:815-20.
14. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-74.
15. Ware JE Jr. SF-36 Health Survey manual and interpretation guide. Boston: The Health Institute, New England Medical Centre, 1993.
16. Younossi ZM, Guyatt G, Kiwi M, et al. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999;45:295-300.
17. Bondini S, Kallman J, Dan A, et al. Health-related quality of life in patients with chronic hepatitis B. Liver Int 2007;27:1119-25.
18. Kallman J, O'Neil MM, Larive B, et al. Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection. Dig Dis Sci 2007;52:2531-9.
19. Córdoba J, Flavià M, Jacas C, et al. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol 2003;39:231-8.
20. Spiegel BM, Younossi ZM, Hays RD, et al. Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology 2005;41:790-800.
21. Ong SC, Mak B, Aung MO, et al. Health-related quality of life in chronic hepatitis B patients. Hepatology 2008;47:1108-17.
22. Bergner M, Bobbitt RA, Carter WB, et al. The sickness impact profile: development and final revision of a health status measure. Med Care 1981;19:787-805.
23. Kind P, Carr-Hill R. The Nottingham health profile: a useful tool for epidemiologists? Soc Sci Med 1987;25:905-10.
24. Ware JE Jr. SF-36 health survey update. Spine 2000;25:3130-9.
25. Fontaine KR, Cheskin LJ, Barofsky I. Health-related quality of life in obese persons seeking treatment. J Fam Pract 1996;43:265-70.
26. Han TS, Tijhuis MA, Lean ME, et al. Quality of life in relation to overweight and body fat distribution. Am J Public Health 1998;88:1814-20.
27. Anderson RM, Fitzgerald JT, Wisdom K, et al. A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care 1997;20:299-305.
28. Weinberger M, Kirkman MS, Samsa GP, et al. The relationship between glycemic control and health-related quality of life in patients with non-insulin-dependent diabetes mellitus. Med Care 1994;32:1173-81.